US5364845A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Glucosamine, chondroitin and manganese composition for the protection and repair of connective tissue
Assignee: Nutramax Laboratories Inc
•
Filing: 1993-03-31
•
Granted: 1994-11-15
•
Expires: 2013-03-31
Abstract
Abstract A therapeutic composition for the protection, treatment and repair of connective tissue in mammals and a method for the treatment of connective tissue in mammals by the administration of the composition. The composition includes glucosamine and preferably chondroitin sulfate. The composition further includes manganese ascorbate which catalyzes the production of collagen and proteoglycans from the glucosamine and the chondroitin sulfate.
Inventors
- 👤 Robert W. Henderson
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 15:41
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7008; A61K31/715; A61K31/726; A61K45/00; A61K45/06; A61P; A61P25/00; A61P25/08; A61P29/00
Claims Analysis
Total Claims: 21
Claim 1
Independent Claim
50 words
A therapeutic composition for the treatment and repair of connective tissue in mammals, comprising: therapeutic quantities of glucosamine and salts thereof, in combination with chondroitin sulfate and soluble salts of manganese, for stimulating production of proteoglycans and collagens in mammals in need thereof for treatment and repairing the connective tissue.
Claim 2
Dependent Claim
50 words
A therapeutic composition for the treatment and repair of connective tissue in mammals, comprising: therapeutic quantities of glucosamine and salts thereof, in combination with chondroitin sulfate and soluble salts of manganese, for stimulating production of proteoglycans and collagens in mammals in need thereof for treatment and repairing the connective tissue.
Claim 3
Dependent Claim
12 words
The therapeutic composition of claim 1, wherein the glucosamine is glucosamine hydrochloride.
Claim 4
Dependent Claim
12 words
The therapeutic composition of claim 1, wherein the glucosamine is glucosamine sulfate.
Claim 5
Dependent Claim
19 words
The therapeutic composition of claim 1, wherein a dose of the glucosamine ranges from 250 mg to 3000 mg.
Claim 6
Dependent Claim
18 words
The therapeutic composition of claim 4, wherein the dose for humans and small mammals is approximately 250 mg.
Claim 7
Dependent Claim
20 words
The therapeutic composition of claim 4, wherein the dose of glucosamine for horses and large mammals is approximately 1800 mg.
Claim 8
Dependent Claim
19 words
The therapeutic composition of claim 1, wherein a dose of chondroitin sulfate ranges from 50 mg to 1000 mg.
Claim 9
Dependent Claim
21 words
The therapeutic composition of claim 7, wherein the dose of chondroitin sulfate for humans and small mammals is approximately 200 mg.
Claim 10
Dependent Claim
21 words
The therapeutic composition of claim 7, wherein the dose of chondroitin sulfate for horses and large mammals is approximately 600 mg.
Claim 11
Dependent Claim
14 words
The therapeutic composition of claim 1, wherein the soluble manganese salt is manganese ascorbate.
Claim 12
Dependent Claim
19 words
The therapeutic composition of claim 10, wherein the dose of manganese ascorbate ranges from 75 mg to 950 mg.
Claim 13
Dependent Claim
21 words
The therapeutic composition of claim 11, wherein the dose of manganese ascorbate for horses and large mammals is approximately 120 mg.
Claim 14
Dependent Claim
49 words
The therapeutic composition of claim 1, wherein the dose of glucosamine ranges from 250 mg to 3000 mg, the dose of chondroitin sulfate ranges from 50 mg to 1000 mg, the manganese salt is manganese ascorbate and the dose of manganese ascorbate ranges from 15 mg to 950 mg.
Claim 15
Dependent Claim
21 words
The therapeutic composition of claim 10, wherein the dose of manganese ascorbate for humans and small mammals is approximately 38 mg.
Claim 16
Dependent Claim
33 words
The therapeutic composition of claim 13, wherein the dose for humans and small mammals is approximately 250 mg of glucosamine, approximately 200 mg of chondroitin sulfate and approximately 38 mg of manganese ascorbate.
Claim 17
Dependent Claim
33 words
The therapeutic composition of claim 13, wherein the dose for horses and large mammals is approximately 1800 mg of glucosamine, approximately 600 mg of chondroitin sulfate and approximately 120 mg of manganese ascorbate.
Claim 18
Independent Claim
60 words
A method for the, treatment and reparation of connective tissue in mammals, comprising the steps of administering a therapeutically effective quantity of glucosamine, including salts thereof, chondroitin sulfate and a soluble manganese salt to a mammal in need thereof, whereby the mammal's natural production of collagen and proteoglycans is increased for treating and repairing the connective tissue of the mammal.
Claim 19
Independent Claim
60 words
A method for the, treatment and reparation of connective tissue in mammals, comprising the steps of administering a therapeutically effective quantity of glucosamine, including salts thereof, chondroitin sulfate and a soluble manganese salt to a mammal in need thereof, whereby the mammal's natural production of collagen and proteoglycans is increased for treating and repairing the connective tissue of the mammal.
Claim 20
Independent Claim
61 words
A method for the treatment and reparation of connective tissue in mammals, comprising the steps of orally administering a therapeutically effective quantity of glucosamine, including salts thereof, chondroitin sulfate and a soluble manganese salt to a mammal in need thereof, whereby the mammal's natural production of collagen and proteoglycans is increased for treating and repairing the connective tissue of the mammal.
Claim 21
Independent Claim
61 words
A method for the treatment and reparation of connective tissue in mammals, comprising the steps of orally administering a therapeutically effective quantity of glucosamine, including salts thereof, chondroitin sulfate and a soluble manganese salt to a mammal in need thereof, whereby the mammal's natural production of collagen and proteoglycans is increased for treating and repairing the connective tissue of the mammal.
References Cited (Backward Citations)
US3232836A
Cited
US3371012A
Cited
US3697652A
Cited
US3683076A
Cited
US4006224A
Cited
US4414202A
Cited
US4486416A
Cited
US4647453A
Cited
US4801619A
Cited
US4772591A
Cited
US4983580A
Cited
US5162303A
Cited
US5141928A
Cited
US5141928B1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-11-14 | 1998-05-16 | 1998-11-15 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-11-14 | 2002-05-16 | 2002-11-15 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-11-14 | 2006-05-16 | 2006-11-15 | $7700.00 | Window Closed / Lapsed |